Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/SCICLONE-PHARMACEUTICALS--119962474/nieuws/SciClone-Pharmaceuticals-Holdings-Limited-kondigt-aan-dat-de-Fase-III-klinische-studie-van-Vaborem-45862863/?utm_source=whatsapp&utm_medium=social&utm_campaign=share